Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer
Background and purpose: With the increasing application of immune checkpoint inhibitors in lung cancer, immune-related adverse event (irAE) has attracted more and more attention. This study aimed to analyze the occurrence of irAE in patients receiving single-drug immunotherapy and the corr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2021-03-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/20210307.pdf |